文献速递心血管CT

冠状动脉CT血管成像联合CT灌注与单纯冠状动脉CT血管成像:评估胸痛方案的系统综述与Meta分析

Coronary CT angiography alone versus with CT perfusion: a systematic review and meta-analysis assessing approaches for chest pain.
PubMed 文献 · Eur Radiol · 2025-03-07

该系统综述与Meta分析纳入7项双臂及单臂研究共3587例患者,比较CCTA联合CTP与单纯CCTA评估胸痛。在中位随访17个月时,两组MACE(OR 1.19,95%CI 0.91-1.57,p=0.21)和全因死亡(OR 0.41,0.11-1.47,p=0.17)相似;单纯CCTA组总ICA(OR 2.42,1.99-2.94,p<0.00001)及未后续血运重建的ICA(OR 2.85,1.23-6.61,p=0.01)更高,而CCTA联合CTP组后续血运重建的ICA更高(OR 0.39,0.22-0.69,p=0.001)。

要点

  • CCTA联合CTP与单纯CCTA相比,MACE和全因死亡无显著差异。
  • 单纯CCTA组总ICA及未血运重建的ICA更高,CCTA联合CTP组后续血运重建的ICA更高。
  • 负荷CTP联合CCTA可减少不必要的侵入性冠状动脉造影并提高血运重建率。

核心结论

  • 基于灌注评估联合解剖评估的冠状动脉影像方案与单纯CCTA在长达2年的MACE、心肌梗死和非计划血运重建方面相当。

研究设计与样本

  • 系统综述与Meta分析,纳入7项双臂及单臂研究(2项随机对照试验和5项观察性研究),共3587例患者,其中2101例接受CTP联合CCTA、1486例接受单纯CCTA;主要分析纳入4项比较CCTA联合CTP与单纯CCTA的研究,次要分析分析全部7项研究各结局发生率。

诊断标准与关键数值

  • 主要分析中位随访17个月,MACE的OR 1.19(95%CI 0.91-1.57,p=0.21),全因死亡OR 0.41(0.11-1.47,p=0.17)。
  • 单纯CCTA组总ICA的OR 2.42(1.99-2.94,p<0.00001),未后续血运重建的ICA的OR 2.85(1.23-6.61,p=0.01)。
  • CCTA联合CTP组后续血运重建的ICA的OR 0.39(0.22-0.69,p=0.001)。
  • 复发性心肌梗死OR 0.94(0.15-5.83,p=0.95),非计划血运重建OR 0.69(0.19-2.51,p=0.57),95%CI均跨1。

临床应用与阅片要点

  • 负荷CTP联合CCTA可减少不必要的侵入性冠状动脉造影并提高血运重建率,且未显著影响MACE、心肌梗死或非计划血运重建。
  • 将负荷CTP纳入CCTA可通过减少不必要的侵入性操作和改善定制治疗策略来优化诊疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the prognostic value of stress Computed Tomography Perfusion (CTP) in patients with suspected or known coronary artery disease.

MATERIALS AND METHODS: All studies evaluating patients with chest pain with CTP plus coronary computed tomography angiography (CCTA) alone or versus CCTA were included. The primary analysis included studies comparing CCTA plus CTP vs CCTA alone, while in the secondary analysis we analyzed the incidence of each outcome across all seven studies, two- and single-arm.

RESULTS: Seven double- and single-arm studies were included (two randomized controlled trials and five observational ones) with 3587 patients (2101 evaluated with CTP plus CCTA and 1486 with CCTA alone).In the primary analysis including 4 studies, after a median follow-up of 17 months, the rates of MACEs (OR 1.19, 95% CI 0.91-1.57, p = 0.21) and all-cause death (OR 0.41, 0.11-1.47, p = 0.17) were similar. Patients managed according to CCTA alone had higher rates of total ICA (OR 2.42, 1.99-2.94, p < 0.00001) and ICA without subsequent revascularization (OR 2.85, 1.23-6.61, p = 0.01). Conversely, the rate of ICA with subsequent revascularization was higher in patients who underwent CCTA plus CTP (OR 0.39, 0.22-0.69, p = 0.001). There were no significant differences in terms of recurrent MI (OR 0.94, 0.15-5.83, p = 0.95) and unplanned revascularization (OR 0.69, 0.19-2.51, p = 0.57, all CI 95%) between the two approaches. These results were confirmed in the secondary analysis.

CONCLUSION: A coronary imaging approach based on perfusion evaluation in addition to anatomic assessment was comparable to CCTA alone in terms of MACE, myocardial infarctions and unplanned revascularizations up to 2 years. Patients evaluated with CTP less frequently underwent ICA, which did, however, result in a higher rate of stent implantation.

KEY POINTS: Question Does the addition of stress Computed Tomography Perfusion (CTP) to coronary computed tomography angiography (CCTA) improve the diagnostic and prognostic evaluation of patients with chest pain compared to CCTA alone? Findings Stress CTP combined with CCTA reduces unnecessary invasive coronary angiography and increases revascularization rates without significantly impacting MACE, myocardial infarction, or unplanned revascularization. Clinical relevance Incorporating stress CTP into CCTA optimizes care by reducing unnecessary invasive procedures and improving tailored treatment strategies for patients with stable and unstable chest pain.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. D'Ascenzo F, Faletti R, Di Pietro G, et al. Coronary CT angiography alone versus with CT perfusion: a systematic review and meta-analysis assessing approaches for chest pain. Eur Radiol. 2025. PMID: 40055231. doi:10.1007/s00330-025-11459-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。